Clinical Trials Directory

Trials / Completed

CompletedNCT04508166

Towards a Post-exposition Pharmacological Prophylaxis for Post-traumatic Stress Disorder

Pharmacological Prevention of Post-traumatic Intrusions in Healthy Volunteers - Towards a Post-exposition Prophylaxis for Post-traumatic Stress Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Psychiatric University Hospital, Zurich · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

In this study, we investigate the role that deep sleep plays in the prevention of posttraumatic stress disorder after someone has been exposed to a trauma by boosting deep sleep with two drug conditions compared to placebo condition. Each volunteer in the study goes through all three conditions. The quantity of intrusive memories of the trauma will be compared between the three conditions.

Detailed description

The present study seeks to investigate the potential to pharmacologically modulate slow-wave sleep in the acute aftermath of an experimentally-induced trauma in the interest of developing a secondary prevention of posttraumatic stress disorder. The effects of a GABAergic compound will be compared with that of a noradrenergic compound. Memory, sleep and stress-related immune response factors will be quantified and compared across drug conditions.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineVolunteers receive a single dose of dexmedetomidine sublingually at scheduled bedrest in the sleep laboratory
DRUGGamma-HydroxybutyrateVolunteers receive a single oral dose of gamma-hydroxybutyrate at scheduled bedrest in the sleep laboratory
DRUGPlaceboVolunteers receive an oral (saline) or sublingual (orodispersible tablet) at scheduled bedrest in the sleep laboratory
BEHAVIORALExperimental Model Trauma FilmEach volunteer views experimental model trauma film before scheduled bedrest in the sleep laboratory. This video is ca. 15 minutes in duration and is composed of short (a few seconds to a few minutes) individual and unrelated scenes of violent death and injury of varying description. Six versions of the film without re-occurring scenes will be presented in balanced order across drug order conditions.

Timeline

Start date
2021-10-01
Primary completion
2022-01-29
Completion
2022-01-29
First posted
2020-08-11
Last updated
2022-10-04

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04508166. Inclusion in this directory is not an endorsement.